Picture:  SARS-CoV-2 virus surrounded by Y-shaped antibody proteins. From JANUARY 12, 2021 For early-onset COVID-19 cases (positive COVID-19 test and at-risk for progression of the disease but not experiencing symptoms requiring hospitalization), emerging evidence has shown three intravenous monoclonal antibodies (MABS) may be useful: the two-antibody drug BAMLANIVIMAB from Eli Lilly and the combination drug […]